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Abstract: IMPORTANCE: Apical ballooning is broadly recognized as the classic form of takotsubo
syndrome (TTS). Atypical subtypes of TTS also exist, which constitute about 20% of all cases. To date,
clinical profile and course of atypical TTS types have rarely been studied. OBJECTIVE: To characterize
the clinical profile and outcomes of typical vs atypical types of TTS in a large patient cohort. DESIGN,
SETTING, AND PARTICIPANTS: Records of 1750 patients from the International Takotsubo Registry,
comprising 26 participating cardiovascular centers in 9 different countries, were reviewed and data on
clinical profile and outcomes collected from January 1, 2011, to December 31, 2014. MAIN OUTCOMES
AND MEASURES: Clinical characteristics and in-hospital as well as long-term outcomes were assessed.
RESULTS: Of 1750 patients diagnosed with TTS between 1998 and 2014, a total of 1430 (81.7%) presented
with apical TTS (defined as typical TTS) and 320 (18.3%) with midventricular, basal, or focal TTS (all
defined as atypical TTS). Patients with atypical TTS were younger than those with typical TTS (mean
[SD], 62.5 [13.3] vs 67.3 [12.9] years; P < .001). Brain natriuretic peptide levels on admission were lower
(median factor increase of the upper limit of normal, 4.18 vs 6.59; P = .02) and left ventricular ejection
fraction was higher (mean [SD], 43.4% [10.7%] vs 40.6% [12.0%]; P < .001) in patients with atypical than
those with typical forms of TTS. ST-segment depression was more prevalent in patients with atypical
TTS (31 of 286 [10.8%] vs 90 of 1292 [7.0%]; P = .03), while ST-segment elevation was found more
frequently in patients with typical TTS (593 of 1292 [45.9%] vs 97 of 286 [33.9%]; P < .001). Patients
with atypical TTS more often had neurologic disorders than those with typical TTS (81 of 274 [29.6%]
vs 286 of 1251 [22.9%]; P = .02). While in-hospital mortality was comparable between patients with
atypical and typical TTS (10 of 320 [3.1%] vs 62 of 1430 [4.3%]; P = .32), the atypical forms showed a
favorable outcome at 1 year (P = .01). However, after adjustment for confounders, only left ventricular
ejection fraction less than 45%, atrial fibrillation, and neurologic disease, but not the type of TTS, were
independent predictors. After 1 year, patients with both types of TTS showed a similar prognosis at long-
term follow-up. CONCLUSIONS AND RELEVANCE: Atypical TTS has different characteristics than
typical TTS, including younger age of onset, more frequent ST-segment depression, higher prevalence
of neurologic diseases, less pronounced reduction in left ventricular ejection fraction, and lower brain
natriuretic peptide values on admission. Outcomes are comparable between patients with both types
after adjustment for confounders, suggesting that both should be equally monitored.
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IMPORTANCE Apical ballooning is broadly recognized as the classic form of takotsubo
syndrome (TTS). Atypical subtypes of TTS also exist, which constitute about 20% of all cases.
To date, clinical profile and course of atypical TTS types have rarely been studied.
OBJECTIVE To characterize the clinical profile and outcomes of typical vs atypical types of TTS
in a large patient cohort.
DESIGN, SETTING, AND PARTICIPANTS Records of 1750 patients from the International
Takotsubo Registry, comprising 26 participating cardiovascular centers in 9 different
countries, were reviewed and data on clinical profile and outcomes collected from January 1,
2011, to December 31, 2014.
MAIN OUTCOMES ANDMEASURES Clinical characteristics and in-hospital as well as long-term
outcomes were assessed.
RESULTS Of 1750 patients diagnosed with TTS between 1998 and 2014, a total of 1430
(81.7%) presented with apical TTS (defined as typical TTS) and 320 (18.3%) with
midventricular, basal, or focal TTS (all defined as atypical TTS). Patients with atypical TTS
were younger than those with typical TTS (mean [SD], 62.5 [13.3] vs 67.3 [12.9] years;
P < .001). Brain natriuretic peptide levels on admission were lower (median factor increase of
the upper limit of normal, 4.18 vs 6.59; P = .02) and left ventricular ejection fraction was
higher (mean [SD], 43.4% [10.7%] vs 40.6% [12.0%]; P < .001) in patients with atypical than
those with typical forms of TTS. ST-segment depression wasmore prevalent in patients with
atypical TTS (31 of 286 [10.8%] vs 90 of 1292 [7.0%]; P = .03), while ST-segment elevation
was foundmore frequently in patients with typical TTS (593 of 1292 [45.9%] vs 97 of 286
[33.9%]; P < .001). Patients with atypical TTSmore often had neurologic disorders than those
with typical TTS (81 of 274 [29.6%] vs 286 of 1251 [22.9%]; P = .02). While in-hospital
mortality was comparable between patients with atypical and typical TTS (10 of 320 [3.1%] vs
62 of 1430 [4.3%]; P = .32), the atypical forms showed a favorable outcome at 1 year (P = .01).
However, after adjustment for confounders, only left ventricular ejection fraction less than
45%, atrial fibrillation, and neurologic disease, but not the type of TTS, were independent
predictors. After 1 year, patients with both types of TTS showed a similar prognosis at
long-term follow-up.
CONCLUSIONS AND RELEVANCE Atypical TTS has different characteristics than typical TTS,
including younger age of onset, more frequent ST-segment depression, higher prevalence of
neurologic diseases, less pronounced reduction in left ventricular ejection fraction, and lower
brain natriuretic peptide values on admission. Outcomes are comparable between patients
with both types after adjustment for confounders, suggesting that both should be equally
monitored.
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T akotsubo syndrome (TTS), also known as broken heartsyndrome or stress cardiomyopathy, was first de-scribed in 19901 as transient apical ballooningof the left
ventricle in the absence of obstructive coronary artery dis-
ease,predominantlypresent in femalepatients.2However,vari-
ants of this syndrome with midventricular,3-6 basal,7-11 and
focal12,13 wall motion patterns were later described. Interest-
ingly,different formsofTTScanalsooccur inthesamepatient.14
As data on atypical forms of TTS are limited, knowledge of
clinical features and outcomes is incomplete. This limited
knowledge probably results in underdiagnosing of TTS,which
poses a major risk to patients, as the adverse outcome of TTS
still remains underrecognized.15 The International Takotsubo
Registry, whichwas founded to systematically investigate the
disease, constitutes the largest cohortofTTSpatients todate.16
Theaimofour studywas toprovideacomprehensivechar-
acterization of features and outcomes of atypical TTS vari-
ants in the International Takotsubo Registry and to compare
these forms to apical ballooning.
Methods
Data Collection
The International TakotsuboRegistry (http://www.takotsubo
-registry.com) is an ongoing prospective and retrospective
observational registry currentlywith 26 participating centers
from 9 countries (eAppendix 1 in the Supplement). The first
results on 1750patients includinggeneral clinical features and
outcomeshaverecentlybeenpublishedelsewhere.16Adetailed
description of the inclusion criteria, definition of the formsof
TTS, and data collection is provided in eAppendix 2 in the
Supplement.
Records of 1750patientswere reviewed anddata on clini-
cal profile and outcomes collected from January 1, 2011, to
December 31, 2014. Follow-up includeddeath fromany cause
and major adverse cardiac and cerebrovascular events (com-
posite of recurrentTTS,myocardial infarction, stroke, or tran-
sient ischemic attackordeath fromanycause),whichwere as-
sessed frommedical records, telephone follow-up, or clinical
visits. Complete details on follow-up have been recently
reported.16 The study protocol was reviewed by the respec-
tive local ethics committees or investigational review boards
at each collaboration site. Due to the in part retrospective na-
ture of the study, ethics committees of most study centers
waived theneed for informedconsent.At centers inwhich the
ethics committees or investigational review boards required
informedconsent or inwhichpatientswere includedprospec-
tively, formal written consent was obtained from patients or
surrogates.
Statistical Analysis
Differences between groups were calculated using the
Pearson χ2 test or the Fisher exact test. Laboratory
parameters were compared using the Mann-Whitney test
and Kruskal-Wallis test. The remaining continuous data
were compared using an unpaired t test and one-way analy-
sis of variance. Survival was analyzed using Kaplan-Meier
estimates and log-rank test, as well as a landmark analysis
with a landmark set at 1 year. Statistical analyses were per-
formed using SPSS, version 22.0 (IBM Corp). P < .05
(2-sided) was considered statistically significant. All graphs
were compiled with Prism 6 (GraphPad).
Results
Patient Characteristics
AtypicalTTSwaspresent in320patients (18.3%), including the
midventricular (255 [14.6%]), basal (39 [2.2%]), and focal (26
[1.5%]) forms (Figure 1; eTable 1 in the Supplement).16 During
the period from 1998 to 2014, atypical TTS was increasingly
diagnosed (eFigure 1 in the Supplement). Patientswith atypi-
calTTSwereyounger thanpatientswith typicalTTS ([SD],62.5
[13.3]vs67.3 [12.9]years;P < .001), andpatientswithbasalTTS
were the youngest among the subgroup of those with atypi-
calTTS (Table; eTable 1 andeTable2 in theSupplement).There
were no differences between patients with typical and atypi-
cal TTS in symptomson admission and emotional (P = .09) or
physical (P = .46) triggering factors;however,asubgroupanaly-
sis revealed that the basal formmost often occurred without
an identifiable trigger (17 of 39 [43.6%] [Table; eTable 1 and
eTable 2 in the Supplement]).
Laboratory Values
On admission, levels of brain natriuretic peptide (BNP) were
higher inpatientswith typicalTTSthanthosewithatypicalTTS
(median factor increase of the upper limit of normal, 6.59 vs
4.18; P = .02). In contrast, levels of troponin and creatine ki-
nase were not different between both groups. Levels of
C-reactive protein on admission were higher in patients with
typical vs atypical TTS (eTable 2 in the Supplement).
ElectrocardiogramResults
Compared with those with atypical TTS, patients with typi-
cal TTS more often had atrial fibrillation (7.7% [100 of 1298]
vs 4.2% [12 of 286]; P = .04), ST-segment elevation (45.9%
[593 of 1292] vs 33.9% [97 of 286]; P < .001), and T-wave
inversion (42.4% [548 of 1292] vs 35.0% [100 of 286];
P = .02). In contrast, ST-segment depression was more
Key Points
Question What are the differences in clinical profile and
outcomes between typical and atypical takotsubo syndrome
(TTS)?
Findings Patients with typical and atypical TTS are characterized
by distinct clinical profiles, and substantial but comparable
in-hospital complication rates, including cardiogenic shock and
death. One-year mortality is higher in patients with typical TTS,
but after adjustment for confounders, only left ventricular ejection
fraction less than 45%, atrial fibrillation, and neurologic disease,
but not type of TTS, are independent predictors of death.
Meaning Patients with typical and atypical TTS should be equally
and closely monitored.
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prevalent among patients with atypical TTS (10.8% [31 of
286] vs 7.0% [90 of 1292]; P = .03), particularly in those with
the basal form (7 of 38 [18.4%]). While duration of QTc as a
hallmark of TTS did not differ between patients with typical
and atypical TTS (mean QTc, 458.7 vs 452.7 milliseconds;
P = .08), those with the basal form exhibited significantly
longer QTc times (mean, 477.3 milliseconds; P = .01) (Table;
eTable 1 and eTable 2 in the Supplement).
Hemodynamic Findings
Patientswith typical TTS had a lower left ventricular ejection
fraction (LVEF) on admission (mean [SD], 40.6% [12.0%] vs
43.4% [10.7%];P < .001) thanpatientswith atypical TTS,with
the focal form having the highest LVEF (mean [SD], 50.8%
[13.6%]) (Figure 1, Table; eTable 1 and eTable 2 in the Supple-
ment). Of note, LVEF recovered to normal levels irrespective
of the initial form of TTS (eFigure 2 in the Supplement).
Neurologic and Psychiatric Comorbidities
Patientswith typical TTSmore often presentedwith an acute
psychiatric episode than those with atypical TTS (10.5% [132
of 1254] vs 6.3% [17 of 271]; P = .03), while patients with an
atypical form more often presented with a neurologic disor-
der (29.6% [81 of 274] vs 22.9% [286 of 1251]; P = .02) (Table;
eTable 2 in the Supplement).
Outcomes
There were no significant differences between patients with
typical and atypical TTS regarding the incidence of in-
hospital complications, such as cardiogenic shock (10.5% [147
of 1404]vs7.4%[23of312];P = .10),and in-hospitaldeath (4.3%
[62of 1430] vs 3.1% [10of 320];P = .32) (Table; eTable 2 in the
Supplement). The focal form of TTS showed the most favor-
able outcome, with no cases of cardiogenic shock or in-
hospital death (eTable 1 in the Supplement). Accordingly, the
frequency of acute cardiac care did not differ between pa-
tients with typical and atypical TTS (20.1% [285 of 1421] vs
23.9% [75 of 341]; P = .13) (eTable 2 in the Supplement).
Long-term follow-up demonstrated comparable rates of
major adverse cardiac and cerebrovascular events in patients
with typical and atypical TTS (10.0% vs 9.2%, respectively;
P = .42), while the difference in mortality showed borderline
significance between the groups (6.0%vs 3.9%, respectively;
P = .05; eTable 2 in the Supplement). We therefore per-
formed a landmark survival analysis, showing a substantially
increasedmortality rate at theprespecified landmarkof 1 year
inpatientswith typicalTTS (P = .01); however, after thatpoint,
mortality rates were comparable between both types of TTS
(P = .99; Figure 2). More important, results of a multivariate
analysis revealed that the type of TTS was not an indepen-
dent predictor of mortality at 1 year, in contrast to LVEF less
than 45%, atrial fibrillation, and the presence of neurologic
disease (eFigure 3 in the Supplement).
Discussion
This study is the first, to our knowledge, to determine clinical
characteristics and outcomes of patients with atypical TTS in
a large patient population. We found several differences
Figure 1. Four DifferentWall Motion Patterns in Takotsubo Syndrome
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betweenpatientswith atypical and typical TTS. Patientswith
atypical TTS are slightly younger than those with typical TTS
and more often experience neurologic comorbidities. There-
fore, one may speculate that neurologic disorders alter a pa-
tient’s susceptibility forTTS ingeneral aswell asparticularpat-
terns of wall motion abnormalities in response to a triggering
event.
Typical TTS usually affects a large extent of the myocar-
dium. The BNP levels were consistently higher and LVEFwas
lower in patients with typical TTS compared with those with
atypical TTS. Themost preserved LVEFwas found in patients
with focalTTS.Thus,TTSoccurs inaspectrumofdifferentphe-
notypes,with focal TTSappearingas themildest variant of the
disease.
Contrary to thecommonbelief that triggering factorsmight
differ between types,11,17 our data show that theprevalence of
emotional or physical triggers is comparable betweengroups.
This finding demonstrates that the small sample sizes in pre-
viousstudiescanexertaprofoundlimitation.Wefurtherspecu-
late that individualswhopresentwith a triggering factor have
ahigherprobability tobediagnosedwithTTS than thosewith-
out such factors, representing a relevant awareness bias
during clinical routine.
It appears likely that the differentwallmotion patterns in
patients with typical and atypical TTS translate into differ-
ences inECGpatterns. Althoughprevious studies didnot find
such differences,18 we identified significantly more frequent
ST-segment elevations and T-wave inversions and less fre-
quent ST-segment depressions in patients with typical TTS.
Considering thehigher BNPvalues, lower LVEF, and larger af-
fected area of the myocardium in the presence of rather low
creatine kinase and troponin levels compared with acute
Table. Characteristics of Patients with TTS
Characteristic
Valuea
P Value
Typical TTS
(n = 1430)
Atypical TTS
(n = 320)
Demographics
Female sex 1284 (89.8) 287 (89.7) .96
Age, mean (SD), y 67.3 (12.9) 62.5 (13.3) <.001
Triggers
Physical 509 (35.6) 121 (37.8) .46
Emotional 384 (26.9) 101 (31.6) .09
Both emotional and physical 111 (7.8) 26 (8.1) .83
No evident 426 (29.8) 72 (22.5) .009
Symptoms on admission
Chest pain 1014 of 1325 (76.5) 215 of 294 (73.1) .22
Dyspnea 623 of 1320 (47.2) 137 of 300 (45.7) .63
ECG on admission
ST-segment
Elevation 593 of 1292 (45.9) 97 of 286 (33.9) <.001
Depression 90 of 1292 (7.0) 31 of 286 (10.8) .03
Hemodynamic findings, mean (SD)
Heart rate, beats/min 87.9 (21.5) 85.8 (23.3) .15
No. of patients 1173 274
Systolic blood pressure, mm Hg 130.3 (29.1) 132.1 (27.6) .33
No. of patients 1168 280
Left ventricular ejection fraction, %b 40.6 (12.0) 43.4 (10.7) <.001
No. of patients 1312 287
Neurologic or psychiatric disordersc 580 of 1251 (46.4) 134 of 274 (48.9) .45
Neurologic disorders, totalc 286 of 1251 (22.9) 81 of 274 (29.6) .02
Acute 110 of 1255 (8.8) 33 of 273 (12.1) .09
Past or chronic 229 of 1238 (18.5) 64 of 274 (23.4) .07
Psychiatric disorders, totalc 404 of 1251 (32.3) 88 of 274 (32.1) .96
Acute 132 of 1254 (10.5) 17 of 271 (6.3) .03
Past or chronic 360 of 1238 (29.1) 84 of 274 (30.7) .60
In-hospital complications and management
Cardiogenic shock 147 of 1404 (10.5) 23 of 312 (7.4) .10
Death 62 (4.3) 10 (3.1) .32
Cardiopulmonary resuscitation 128 of 1421 (9.0) 21 of 314 (6.7) .18
Invasive or noninvasive ventilation 241 of 1421 (17.0) 60 of 314 (19.1) .36
Catecholamine use 177 of 1421 (12.5) 35 of 314 (11.1) .52
Abbreviations:
ECG, electrocardiogram;
TTS, takotsubo syndrome.
a Data are presented as number
(percentage) of patients unless
otherwise indicated.
bData obtained during
catheterization or
echocardiography; if both results
were available, data from
catheterization were used.
c Category includes patients with
either an acute as well as past or
chronic disorder.
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coronary syndrome (ACS), it is tempting to speculate that
changes on ECG results seen in TTS reflect myocardial stun-
ning and reversible damage rather than ischemia or necrosis.
Takotsubo syndrome is usually recognized as a transient
benign disease; however, Templin et al16 demonstrated that
in-hospital complications are comparable between patients
withTTSand thosewithACS.Regarding thedifferences inwall
motion patterns and left ventricular function, we hypoth-
esized that the outcome of typical TTS is worse than that of
atypical TTS.However, despite the younger age, higher LVEF,
and lower BNP values in patients with atypical TTS, the rate
of severe in-hospital complications (eg, lethal arrhythmias, car-
diogenic shock, or death)was as high as in patientswith typi-
cal TTS. Thus, all types of TTS should bemonitored as closely
as patients with ACS.
Long-termfollow-updemonstrated that theborderlinesig-
nificance in mortality was in fact driven by the difference in
the first year after the event. However, adjustment for poten-
tial confounders revealed that the type of TTS was not an in-
dependent predictor ofmortality.We can only speculate that
patients with typical TTS have a longer time to recovery and
increased incidenceofatrial fibrillation, therebyexplainingthat
LVEF is an independent predictor ofmortality.Moreover, our
data also propose that other factors beyond the type of TTS
(such as neurologic disease) may contribute to increased
mortality in patients with typical TTS.
Retrospective observations have inherent limitations but
are of critical value for elucidating understudied diseases.
Notwithstanding the grown expertise in TTS diagnosis in all
participating centers, a referral bias cannot be excluded.
Conclusions
OurstudyemphasizesthatatypicalTTSaccounts fornearly20%
of all cases of TTS and has different clinical features than
typical TTS, including younger patient age, more frequent
ST-segment depression, higher prevalence of neurologic dis-
ease, less impaired LVEF, and lower BNP values. Of all forms,
focal TTS appears to have the most favorable outcome. Com-
parison of patientswith typical and atypical TTS reveals simi-
lar in-hospital complicationratesandoutcomes.LVEF less than
45%, atrial fibrillation, and the presence of neurologic disease
are independent predictors of death at 1-year follow-up.
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